These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 20308613

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. FXIIa inhibitor rHA-Infestin-4: Safe thromboprotection in experimental venous, arterial and foreign surface-induced thrombosis.
    May F, Krupka J, Fries M, Thielmann I, Pragst I, Weimer T, Panousis C, Nieswandt B, Stoll G, Dickneite G, Schulte S, Nolte MW.
    Br J Haematol; 2016 Jun; 173(5):769-78. PubMed ID: 27018425
    [Abstract] [Full Text] [Related]

  • 3. Factor XIIa inhibition by Infestin-4: in vitro mode of action and in vivo antithrombotic benefit.
    Xu Y, Cai TQ, Castriota G, Zhou Y, Hoos L, Jochnowitz N, Loewrigkeit C, Cook JA, Wickham A, Metzger JM, Ogletree ML, Seiffert DA, Chen Z.
    Thromb Haemost; 2014 Apr 01; 111(4):694-704. PubMed ID: 24336918
    [Abstract] [Full Text] [Related]

  • 4. The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
    Krupka J, May F, Weimer T, Pragst I, Kleinschnitz C, Stoll G, Panousis C, Dickneite G, Nolte MW.
    PLoS One; 2016 Apr 01; 11(1):e0146783. PubMed ID: 26815580
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Defective thrombus formation in mice lacking coagulation factor XII.
    Renné T, Pozgajová M, Grüner S, Schuh K, Pauer HU, Burfeind P, Gailani D, Nieswandt B.
    J Exp Med; 2005 Jul 18; 202(2):271-81. PubMed ID: 16009717
    [Abstract] [Full Text] [Related]

  • 7. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D, Renné T.
    Arterioscler Thromb Vasc Biol; 2007 Dec 18; 27(12):2507-13. PubMed ID: 17916770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Targeting coagulation factor XII as a novel therapeutic option in brain trauma.
    Hopp S, Albert-Weissenberger C, Mencl S, Bieber M, Schuhmann MK, Stetter C, Nieswandt B, Schmidt PM, Monoranu CM, Alafuzoff I, Marklund N, Nolte MW, Sirén AL, Kleinschnitz C.
    Ann Neurol; 2016 Jun 18; 79(6):970-82. PubMed ID: 27043916
    [Abstract] [Full Text] [Related]

  • 10. The full-length cDNA of anticoagulant protein infestin revealed a novel releasable Kazal domain, a neutrophil elastase inhibitor lacking anticoagulant activity.
    Lovato DV, Nicolau de Campos IT, Amino R, Tanaka AS.
    Biochimie; 2006 Jun 18; 88(6):673-81. PubMed ID: 16469426
    [Abstract] [Full Text] [Related]

  • 11. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T, Nieswandt B, Gailani D.
    Blood Cells Mol Dis; 2006 Jun 18; 36(2):148-51. PubMed ID: 16466946
    [Abstract] [Full Text] [Related]

  • 12. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C, Stoll G, Bendszus M, Schuh K, Pauer HU, Burfeind P, Renné C, Gailani D, Nieswandt B, Renné T.
    J Exp Med; 2006 Mar 20; 203(3):513-8. PubMed ID: 16533887
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of a novel factor XIIa inhibitor in the hematophagous insect, Triatoma infestans (Hemiptera: Reduviidae).
    Campos IT, Tanaka-Azevedo AM, Tanaka AS.
    FEBS Lett; 2004 Nov 19; 577(3):512-6. PubMed ID: 15556638
    [Abstract] [Full Text] [Related]

  • 14. The Kazal-type inhibitors infestins 1 and 4 differ in specificity but are similar in three-dimensional structure.
    Campos IT, Souza TA, Torquato RJ, De Marco R, Tanaka-Azevedo AM, Tanaka AS, Barbosa JA.
    Acta Crystallogr D Biol Crystallogr; 2012 Jun 19; 68(Pt 6):695-702. PubMed ID: 22683792
    [Abstract] [Full Text] [Related]

  • 15. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ, van der Meijden PE, Feijge MA, Mattheij NJ, May F, Govers-Riemslag J, Meijers JC, Heemskerk JW, Renné T, Cosemans JM.
    Arterioscler Thromb Vasc Biol; 2014 Aug 19; 34(8):1674-80. PubMed ID: 24855058
    [Abstract] [Full Text] [Related]

  • 16. Alleviation of secondary brain injury, posttraumatic inflammation, and brain edema formation by inhibition of factor XIIa.
    Hopp S, Nolte MW, Stetter C, Kleinschnitz C, Sirén AL, Albert-Weissenberger C.
    J Neuroinflammation; 2017 Feb 20; 14(1):39. PubMed ID: 28219400
    [Abstract] [Full Text] [Related]

  • 17. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M, Golino P, Cirillo P, Pascucci I, Scognamiglio A, Ravera A, Esposito N, Battaglia C, Guarino A, Chiariello M.
    Cardiologia; 1996 Jan 20; 41(1):51-8. PubMed ID: 8697470
    [Abstract] [Full Text] [Related]

  • 18. Novel roles for factor XII-driven plasma contact activation system.
    Müller F, Renné T.
    Curr Opin Hematol; 2008 Sep 20; 15(5):516-21. PubMed ID: 18695377
    [Abstract] [Full Text] [Related]

  • 19. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T, Gailani D.
    Expert Rev Cardiovasc Ther; 2007 Jul 20; 5(4):733-41. PubMed ID: 17605651
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.
    Stegner D, Thielmann I, Kraft P, Frohman MA, Stoll G, Nieswandt B.
    Arterioscler Thromb Vasc Biol; 2013 Sep 20; 33(9):2212-7. PubMed ID: 23868933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.